Leveraging molecular structure and bioactivity with chemical language models for de novo drug design

HIGHLIGHTS

• who: Michael Moret from the ETH Zurich, Department of Chemistry and Applied Biosciences, Vladimir-Prelog-Weg, Zurich, Switzerland University of Zurich, University Children`s have published the Article: Leveraging molecular structure and bioactivity with chemical language models for de novo drug design, in the Journal: (JOURNAL) of 26/Oct/2021

SUMMARY

Slope 1 + K Hill=DoseHillSlope d where the Hill slope was set to -1. Cells and cell culture for in-cell activity analysis HD-MBO3 Group 3 medulloblastoma cells were cultured in RPMI medium supplemented with 10% fetal bovine serum (FBS, both . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.